Lyka Labs - Quaterly Results

02 Nov 2023 Evaluate
The Revenue for the quarter ended  September 2023 of Rs. 267.60 millions grew by 20.94 % from Rs. 221.27 millions.The Net Loss for the quarter ended September 2023 is Rs. -2.92 millions as compared to Net Loss of Rs. -3.96 millions of corresponding quarter ended September 2022Operating Profit reported a sharp decline to 42.40 millions from 57.70 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 267.60 221.27 20.94 479.97 440.05 9.07 805.93 1643.49 -50.96
Other Income 3.04 10.39 -70.74 7.32 17.23 -57.52 34.52 27.20 26.91
PBIDT 42.40 57.70 -26.52 72.25 123.74 -41.61 190.52 1002.19 -80.99
Interest 11.71 29.14 -59.81 25.04 57.15 -56.19 115.70 199.21 -41.92
PBDT 30.24 27.19 11.22 46.76 65.21 -28.29 3.08 756.30 -99.59
Depreciation 34.63 34.55 0.23 67.98 68.69 -1.03 135.16 153.89 -12.17
PBT -4.39 -7.36 -40.35 -21.22 -3.48 509.77 -132.08 602.41 -121.93
TAX -1.47 -3.40 -56.76 -1.10 -2.79 -60.57 0.78 203.38 -99.62
Deferred Tax -2.47 -3.40 -27.35 -4.45 -2.79 59.50 -1.29 203.38 -100.63
PAT -2.92 -3.96 -26.26 -20.12 -0.69 2815.94 -132.86 399.03 -133.30
Equity 330.90 286.90 15.34 330.90 286.90 15.34 306.90 286.90 6.97
PBIDTM(%) 15.84 26.08 -39.24 15.05 28.12 -46.47 23.64 60.98 -61.23

Lyka Labs Share Price

78.32 -2.72 (-3.36%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×